Renaissance Technologies Portfolio holdings
Renaissance Technologies is a hedge fund firm that trades with computer models built on mathematics and statistics. It began in 1978 as Monemetrics, founded by Jim Simons, a mathematician and former Cold War codebreaker, and took its current name in 1982. The firm launched its Medallion Fund in 1988 and staffs its research with mathematicians, statisticians, physicists, astronomers and computer scientists. Medallion trades over short time spans across many asset types, and it has been closed to outside investors since 1993, open only to current and past employees and their families.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.52% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Mastercard
MA
$556B
| $582M | 0.92% |
5,641,400
-2,700
| -0% | -$280K |
2013 Q2
14 quarters
|
|
2
Colgate-Palmolive
CL
$76.2B
| $553M | 0.88% |
8,453,600
+1,605,600
| +23% | +$110M |
2013 Q2
14 quarters
|
|
3
Novo Nordisk
NVO
$176B
| $500M | 0.79% |
27,891,800
-1,415,200
| -5% | -$25.7M |
2013 Q2
14 quarters
|
|
|
LLTC
4
DELISTED
Linear Technology Corp
LLTC
| $482M | 0.76% |
7,733,600
-981,300
| -11% | -$59.8M |
2013 Q2
14 quarters
|
|
5
Costco
COST
$448B
| $451M | 0.71% |
2,819,713
+733,500
| +35% | +$112M |
2013 Q2
14 quarters
|
|
6
NetEase
NTES
$72.8B
| $434M | 0.69% |
10,069,500
+104,000
| +1% | +$4.96M |
2013 Q2
14 quarters
|
|
|
7
Johnson & Johnson
JNJ
$667B
| $394M | 0.62% |
3,423,100
+1,948,000
| +132% | +$225M |
2015 Q3
5 quarters
|
|
|
8
Gilead Sciences
GILD
$215B
| $378M | 0.6% |
5,274,948
+3,327,900
| +171% | +$247M |
2014 Q4
8 quarters
|
|
9
Walt Disney
DIS
$193B
| $378M | 0.6% |
3,623,907
+970,700
| +37% | +$94.6M |
2016 Q2
2 quarters
|
|
10
Chubb
CB
$140B
| $378M | 0.6% |
2,857,461
+1,147,400
| +67% | +$146M |
2015 Q1
7 quarters
|
|
|
AET
11
DELISTED
Aetna Inc
AET
| $353M | 0.56% |
2,842,782
+1,737,100
| +157% | +$208M |
2015 Q3
5 quarters
|
|
12
NVIDIA
NVDA
$4.98T
| $330M | 0.52% |
123,788,000
-4,196,000
| -3% | -$8.77M |
2013 Q4
12 quarters
|
|
13
VeriSign
VRSN
$28B
| $324M | 0.51% |
4,263,376
-450,000
| -10% | -$35.6M |
2013 Q2
14 quarters
|
|
14
Cboe Global Markets
CBOE
$35B
| $324M | 0.51% |
4,386,100
-79,900
| -2% | -$5.5M |
2013 Q2
14 quarters
|
|
|
MON
15
DELISTED
Monsanto Co
MON
| $302M | 0.48% |
2,865,800
+2,080,400
| +265% | +$213M |
2016 Q2
2 quarters
|
|
16
Humana
HUM
$49.6B
| $298M | 0.47% |
1,460,300
+546,596
| +60% | +$104M |
2015 Q2
6 quarters
|
|
17
Alphabet (Google) Class A
GOOGL
$3.47T
| $281M | 0.44% |
7,084,000
-3,396,960
| -32% | -$136M |
2016 Q1
3 quarters
|
|
18
Walmart Inc
WMT
$978B
| $274M | 0.43% |
11,877,300
+3,493,800
| +42% | +$81.5M |
2016 Q1
3 quarters
|
|
19
Duke Energy
DUK
$99.4B
| $264M | 0.42% |
3,396,267
+113,300
| +3% | +$8.68M |
2014 Q1
11 quarters
|
|
20
F5
FFIV
$19.5B
| $261M | 0.41% |
1,804,874
+286,800
| +19% | +$38.9M |
2014 Q3
9 quarters
|
|
21
Amgen
AMGN
$255B
| $260M | 0.41% |
1,778,645
-117,696
| -6% | -$17.7M |
2013 Q2
14 quarters
|
|
22
Domino's
DPZ
$10.3B
| $257M | 0.41% |
1,613,500
+188,900
| +13% | +$30.7M |
2013 Q2
14 quarters
|
|
23
Crown Castle
CCI
$38.2B
| $256M | 0.41% |
2,954,903
+1,128,703
| +62% | +$98.9M |
2015 Q1
7 quarters
|
|
24
Entergy
ETR
$52.6B
| $256M | 0.4% |
6,964,600
+517,000
| +8% | +$18.5M |
2014 Q3
9 quarters
|
|
25
American Electric Power
AEP
$71.4B
| $245M | 0.39% |
3,887,600
+558,392
| +17% | +$34.4M |
2014 Q3
9 quarters
|
|
Similar funds
Renaissance Technologies's Q4 2016 Portfolio in Review
As of Q4 2016, Renaissance Technologies held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Renaissance Technologies deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,791 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Renaissance Technologies's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Renaissance Technologies's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Renaissance Technologies fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Renaissance Technologies's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Renaissance Technologies opened 418 new positions and closed 493 in Q4 2016.
- Renaissance Technologies's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.